Back
ESC2025 Premium Access

The clinical significance of atrial fibrillation in non-high risk Brugada syndrome - The BruFib Study

Session: New insights from atrial fibrillation monitoring and screening
Topic: Genetic Causes
Speaker: Doctor E. Scheirlynck (Lugano, CH)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Esther Scheirlynck

Cardiocentro Ticino Institute, Lugano (Switzerland)
1 presentation
0 follower

5 more presentations in this session

1-year follow-up in patients identified with possible atrial fibrillation: sub-analysis of the omron heart study

Speaker: Doctor Y. Kakei (Kyoto, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

AI-tools to make smartwatch ECG incrementally closer to clinical application

Speaker: Professor L. Mainardi (Milan, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Fully digital enrollment in the NORwegian atrial fibrillation self-SCREENing trial (NORSCREEN)

Speaker: Mr M. Boskovic (Oslo, NO)

Access
Abstract
Slides
Video
Like
Thumbnail

Hypokalemia as a trigger for atrial fibrillation: Insights from patients with implantable loop recorders

Speaker: Mr A. Krebs Hessellund (Copenhagen, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Atrial fibrillation screening effects according to genetic risk: a secondary analysis of the randomized LOOP study

Speaker: Mr O. Vad (Copenhagen, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

New insights from atrial fibrillation monitoring and screening

Speakers: Doctor E. Scheirlynck, Doctor Y. Kakei, Professor L. Mainardi, Mr M. Boskovic, Mr A. Krebs Hessellund...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources